Back
Spero Therapeutics Vs. Arbutus Biopharma Industry Stock Comparison
Sell
16
SPRO
Spero Therapeutics
Last Price:
1.18
Seasonality Move:
6.24%
Sell
37
ABUS
Arbutus Biopharma
Last Price:
3.51
Seasonality Move:
15.21%
Sell
16
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy, Sell or Hold?
- The current Spero Therapeutics [SPRO] share price is $1.19. The Score for SPRO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- SPRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPRO Stock Price Chart
What is Spero Therapeutics's stock price today?
-
The Spero Therapeutics share price today is $1.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing selling pressure, which indicates risk of future bearish movement.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.
SPRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.28 | Sell |
| Chaikin Money Flow: | 64496 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 34.97 | Sell |
| Chaikin Money Flow: | 429896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.59 - 4.01) | Sell |
| Bollinger Bands (100): | (3.58 - 4.12) | Sell |
SPRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.22 | Sell |
| 20-day SMA: | 1.26 | Sell |
| 50-day SMA: | 1.28 | Sell |
| 200-day SMA: | 1.43 | Sell |
| 8-day EMA: | 1.21 | Sell |
| 20-day EMA: | 1.24 | Sell |
| 50-day EMA: | 1.27 | Sell |
| 200-day EMA: | 1.38 | Sell |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.54 | Sell |
| 20-day SMA: | 3.74 | Sell |
| 50-day SMA: | 3.89 | Sell |
| 200-day SMA: | 3.38 | Buy |
| 8-day EMA: | 3.55 | Sell |
| 20-day EMA: | 3.69 | Sell |
| 50-day EMA: | 3.8 | Sell |
| 200-day EMA: | 3.43 | Buy |
Spero Therapeutics Earnings Growth & SPRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and an increase next year of $0.58 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Spero Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arbutus Biopharma Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||